Zeteletinib structure
|
Common Name | Zeteletinib | ||
|---|---|---|---|---|
| CAS Number | 2216753-97-6 | Molecular Weight | 500.47 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H23F3N4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ZeteletinibZeteletinib (BOS-172738) shows selective inhibitory activity against RET, PDGFR, KIT, NTRK and FLT3 kinases. Zeteletinib has antitumor activity[1]. |
| Name | Zeteletinib |
|---|
| Description | Zeteletinib (BOS-172738) shows selective inhibitory activity against RET, PDGFR, KIT, NTRK and FLT3 kinases. Zeteletinib has antitumor activity[1]. |
|---|---|
| Related Catalog | |
| Target |
PDGFR |
| References |
[1]. Inagaki, Hiroaki, et al.Preparation of pyridine compound as RET kinase inhibitors.WO2018060714A1. |
| Molecular Formula | C25H23F3N4O4 |
|---|---|
| Molecular Weight | 500.47 |
| InChIKey | KOLQINCWMXQEOF-UHFFFAOYSA-N |
| SMILES | COc1cc2cc(-c3ccc(CC(=O)Nc4cc(C(C)(C)C(F)(F)F)no4)cn3)cnc2cc1OC |